Turning Cell Signaling against Cancer
Researchers Use Single-Molecule Assays, Splice-Switching Oligonucleotides, and Fusion Constructs
Virus Supply Vexes Gene Therapy Developers, CMOs
Some Contract Manufacturing Organizations Are Ramping Up Capacity in Preparation for a Boom in Viral Vector Demand
Ovarian Cancer Stem Cells: Unraveling a Germline Connection
Stem Cells, the Holy Grail for Tissue Regeneration and Repair, Remain an Elusive Phenomenon in Ovarian Biology
Novel Viral Vectors for Gene Therapy
Synthetic Viral Vectors Show Promise for Mitigating Immune Response to Gene Therapy
For full access to this article login to GEN Select now.
Supplement: Advances in Upstream Technologies Reduce Viral-Contamination Risks
Multilayered Approach Includes Virus-Resistant CHO Cell Lines, Advanced Filtration Technologies, and Careful Raw Material Selection
- Upstream suite in a mAb manufacturing plant. A major component of a virus safety strategy is preventing viruses from entering the upstream process.
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.